Berger Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-377
| Closed | -$239K | – | 427 |
|
|
2025
Q1 | $239K | Sell |
377
-8
| -2% | -$5.07K | 0.02% | 375 |
|
|
2024
Q4 | $274K | Sell |
385
-6
| -2% | -$4.27K | 0.02% | 334 |
|
|
2024
Q3 | $411K | Buy |
391
+6
| +2% | +$6.31K | 0.03% | 256 |
|
|
2024
Q2 | $405K | Buy |
385
+8
| +2% | +$8.41K | 0.03% | 236 |
|
|
2024
Q1 | $363K | Buy |
377
+48
| +15% | +$46.2K | 0.03% | 251 |
|
|
2023
Q4 | $289K | Sell |
329
-3
| -0.9% | -$2.64K | 0.03% | 237 |
|
|
2023
Q3 | $273K | Sell |
332
-20
| -6% | -$16.5K | 0.03% | 222 |
|
|
2023
Q2 | $253K | Buy |
352
+18
| +5% | +$12.9K | 0.03% | 244 |
|
|
2023
Q1 | $274K | Sell |
334
-79
| -19% | -$64.9K | 0.03% | 217 |
|
|
2022
Q4 | $298K | Buy |
413
+8
| +2% | +$5.77K | 0.04% | 199 |
|
|
2022
Q3 | $279K | Sell |
405
-35
| -8% | -$24.1K | 0.04% | 192 |
|
|
2022
Q2 | $260K | Sell |
440
-13
| -3% | -$7.68K | 0.04% | 202 |
|
|
2022
Q1 | $316K | Sell |
453
-7,687
| -94% | -$5.36M | 0.04% | 201 |
|
|
2021
Q4 | $5.14M | Buy |
8,140
+227
| +3% | +$143K | 0.68% | 45 |
|
|
2021
Q3 | $4.79M | Sell |
7,913
-62
| -0.8% | -$37.5K | 0.86% | 35 |
|
|
2021
Q2 | $4.45M | Buy |
7,975
+399
| +5% | +$223K | 0.81% | 43 |
|
|
2021
Q1 | $3.59M | Buy |
+7,576
| New | +$3.59M | 0.78% | 52 |
|